kaposi's sarcoma
Showing 1 - 19 of 19
s From HIV Infection, KSHV Infection, Viral-Related
Recruiting
- HIV
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Kaposi's Sarcoma, HIV Positive, AIDS Trial in New Orleans (aldoxorubicin)
Completed
- Kaposi's Sarcoma
- +2 more
-
New Orleans, LouisianaLouisiana State University Health Science Center
Jan 27, 2022
Risk Factors for Non-HIV-Related Kaposi s Sarcoma
Completed
- Kaposi's Sarcoma
-
Palermo, ItalyUniversita Degli Studi Di Palermo
Mar 11, 2021
Kaposi's Sarcoma Trial in San Francisco (Maraviroc)
Completed
- Kaposi's Sarcoma
-
San Francisco, CaliforniaSan Francisco General Hospital, Clinical Trials Unit
Mar 3, 2021
Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions
Completed
- Kaposi's Sarcoma
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2020
Kaposi's Sarcoma, HHV-8, KSHV Trial run by the NCI (BAY 43-9006)
Terminated
- Kaposi's Sarcoma
- +2 more
- BAY 43-9006
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 11, 2019
Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma
Completed
- HIV Seropositivity
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 11, 2019
HIV-1 Infection, Kaposi's Sarcoma Trial in Worldwide (efavirenz/emtricitabine/tenofovir disoproxil fumarate, etoposide)
Completed
- HIV-1 Infection
- Kaposi's Sarcoma
- efavirenz/emtricitabine/tenofovir disoproxil fumarate
- etoposide
-
Rio de Janeiro, Brazil
- +7 more
Nov 1, 2019
Hodgkin Lymphoma, Non Hodgkin Lymphoma, Kaposi's Sarcoma Trial in Baltimore (FIAU-PET-CT-2, FIAU-PET-CT-4)
Completed
- Hodgkin Lymphoma
- +4 more
- FIAU-PET-CT-2
- FIAU-PET-CT-4
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Sep 13, 2018
Kaposi's Sarcoma Trial in United States (drug, genetic, other, procedure)
Terminated
- Kaposi's Sarcoma
- VEGF inhibitor PTC299
- +7 more
-
La Jolla, California
- +7 more
May 3, 2018
Kaposi's Sarcoma, HIV, HIV Seronegativity Trial run by the NCI (Bevacizumab)
Completed
- Kaposi's Sarcoma
- +2 more
- Bevacizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 7, 2017
Clinical, Laboratory and Epidemiologic Pilot Studies of
Completed
- Acquired Immunodeficiency Syndrome
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Kaposi's Sarcoma Trial in San Francisco (Tc 99m tilmanocept)
Completed
- Kaposi's Sarcoma
- Tc 99m tilmanocept
-
San Francisco, CaliforniaSan Francisco General Hospital
Aug 3, 2016
Kaposi's Sarcoma Trial in Milan (Indinavir in association with Vinblastina +/- Bleomicina)
Completed
- Kaposi's Sarcoma
- Indinavir in association with Vinblastina +/- Bleomicina
-
Milan, ItalyDermatologic Unit, Ospedale Maggiore Policlinico, Milan, Italy
Aug 29, 2016
Adrenal Cortical Cancer, Brain Cancer, Breast Cancer Trial in New York (Proton-decoupled 31P MRS at 1.5T, 1H Spectroscopy at
Completed
- Adrenal Cortical Cancer
- +18 more
- Proton-decoupled 31P MRS at 1.5T
- 1H Spectroscopy at 1.5T and 3T
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Dec 23, 2015
HIV, AIDS, Kaposi's Sarcoma Trial in Durban (Generic HAART Triomune : d4T, 3TC, NVP, Generic HAART Triomune : d4T, 3TC, NVP and
Completed
- HIV
- +3 more
- Generic HAART Triomune : d4T, 3TC, NVP
- Generic HAART Triomune : d4T, 3TC, NVP and chemotherapy ABV
-
Durban, Kwazulu Natal, South AfricaDepartment of Dermatology, King Edward VIII Hospital
Jul 20, 2010
Genetic Factors and Interrelationships for Sexual Orientation,
Completed
- Alcoholism
- +3 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Seroprevalence of Kaposi's Sarcoma Herpes Virus in United States
Completed
- Kaposi's Sarcoma
- Herpesviridae Infection
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
AIDS, HIV Infection, Kaposi's Sarcoma Trial run by the NHGRI (Syngeneic Lymphocytes (CD4+) Cultured with OKT3 (Ortho) and
Completed
- Acquired Immunodeficiency Syndrome
- +2 more
- Syngeneic Lymphocytes (CD4+) Cultured with OKT3 (Ortho) and Interleukin-2 (Chiro
-
Bethesda, MarylandNational Human Genome Research Institute (NHGRI)
Feb 7, 2008